Agilent Technologies, Inc. (A)

Agilent Technologies' stock performance has been influenced by financial results, strategic initiatives, and market conditions. In Q4 Fiscal Year 2025, Agilent reported revenue of $1.86 billion, a 9.4% increase, and a GAAP net income of $434 million. The company reported revenue of $1.67 billion in Q2 Fiscal Year 2025, a 6.0% year-over-year increase. Agilent lowered its annual revenue forecast for fiscal year 2025, expecting $6.68 billion to $6.76 billion. The company reorganized its operating segments in fiscal year 2024, creating the Life Sciences and Diagnostics Markets Group (LDG), Applied Markets Group (AMG), and Agilent CrossLab Group (ACG). The acquisition of BIOVECTRA was finalized in late 2024. Agilent launched the Infinity 3 LC Series and partnered with Monash University to launch a BioDiscovery Hub in late 2024 and December 2025, respectively. Strength in industrial and applied markets helped offset softer demand in life sciences in Q4 fiscal 2025.

Agilent Technologies' demand is influenced by cyclical trends and external factors within its served markets. The company has experienced periods of softer demand from early-stage biotech companies and in academic/government research funding. Agilent's CrossLab business offers a resilient and recurring revenue stream. Agilent's pathology division implemented an enterprise-class demand planning solution to streamline its forecasting process. Long-term growth is driven by secular trends in life sciences and applied markets.

Agilent Technologies, Inc. is a global American company specializing in instruments, software, services, and consumables for laboratories. It was established in 1999 as a spin-off from Hewlett-Packard and has expanded into the pharmaceutical, diagnostics & clinical, and academia & government markets. The company operates in the Healthcare Equipment and Services sector, focusing on Life Sciences, Diagnostics, and Applied Chemical Markets. Agilent's offerings include analytical instruments, software & informatics, services & consumables, and cell analysis & diagnostics.

Agilent Technologies operates in over 110 countries with research and development centers, manufacturing facilities, sales offices, and customer support centers. Its headquarters are in Santa Clara, California. Key global operational hubs and offices are located in North America, Europe, and Asia Pacific.

Agilent Technologies has maintained a strong brand reputation, receiving accolades for corporate responsibility, sustainability, and as an employer. It was ranked No. 10 on Newsweek's 2025 list of America's Most Responsible Companies and No. 2 on Barron's annual list of America's Most Sustainable Companies. Agilent was named to Forbes List of World's Best Employers 2025 and received the 2025 Innovation Award for the Infinity III Hybrid Multisampler. Agilent's manufacturing facility in Waldbronn, Germany, was named a "Global Lighthouse" by the World Economic Forum.

Agilent Technologies, Inc. is a publicly traded company with ownership primarily distributed among institutional investors, holding approximately 75% to over 91% of the company's outstanding shares. Major institutional owners include The Vanguard Group, Inc., BlackRock, Inc., and State Street Investment Management. Insider ownership remains minimal, around 0.20% to 0.25% of the company's stock.